We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

210 hedge funds and large institutions have $767M invested in SANGAMO THERAPEUTICS INC in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $14.1M | Put options by funds: $11M

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

11% more capital invested

Capital invested by funds: $691M → $767M (+$76.4M)

3.17% more ownership

Funds ownership: 54.73% → 57.9% (+3.2%)

2% more funds holding

Funds holding: 205 → 210 (+5)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

Holders
210
Holders Change
+5
Holders Change %
+2.44%
% of All Funds
4.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
55
Reduced
69
Closed
25
Calls
$14.1M
Puts
$11M
Net Calls
+$3.14M
Net Calls Change
-$1.82M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$14.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$10.7M
3
N
Nuveen
North Carolina
+$7.17M
4
Invesco
Invesco
Georgia
+$6.08M
5
Millennium Management
Millennium Management
New York
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.91M
2
CC
Casdin Capital
New York
-$4.06M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74M
5
Nordea Investment Management
Nordea Investment Management
Sweden
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank Julius Baer & Co
176
Bank Julius Baer & Co
Switzerland
$18K -$6.49K -600 -24%
CWM
177
Cranbrook Wealth Management
Michigan
$15K – – –
BFEC
178
Benjamin F. Edwards & Company
Missouri
$14K – – –
BG
179
Bollard Group
Massachusetts
$12K – – –
PCM
180
Penserra Capital Management
California
$11K +$13K +1,204 New
RE
181
RBC Europe
United Kingdom
$9.45K – – –
SFS
182
Sowell Financial Services
Arkansas
$9K -$5.41K -500 -33%
AF
183
Allworth Financial
California
$9K – – –
HWM
184
HighMark Wealth Management
Minnesota
$9K – – –
RFA
185
Reilly Financial Advisors
California
$9K – – –
RIM
186
Rockbridge Investment Management
New York
$9K – – –
Rockefeller Capital Management
187
Rockefeller Capital Management
New York
$9K – – –
FFA
188
Founders Financial Alliance
North Carolina
$9K +$10.8K +1,000 New
Daiwa Securities Group
189
Daiwa Securities Group
Japan
$8K +$1.6K +148 +23%
BFC
190
Bedel Financial Consulting
Indiana
$6K – – –
FHA
191
Flagship Harbor Advisors
Massachusetts
$6K – – –
APA
192
American Portfolios Advisors
New York
$5.91K – – –
Millennium Management
193
Millennium Management
New York
$5.2K +$5.96M +550,732 New
CCM
194
Chiron Capital Management
Florida
$5K +$5.41K +500 New
PNC Financial Services Group
195
PNC Financial Services Group
Pennsylvania
$4K – – –
WT
196
Whittier Trust
California
$4K – – –
BCA
197
Berman Capital Advisors
Georgia
$3K – – –
GEA
198
Glen Eagle Advisors
New Jersey
$2.41K – – –
BWM
199
Baystate Wealth Management
Massachusetts
$2K – – –
ASN
200
Advisory Services Network
Georgia
$2K +$2.16K +200 New
6 7
8
9 10

SGMO Hedge Fund Activity: Q3 2020 in Review

210 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2020, worth a combined $767M — up 11% from $691M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 25 closed out — a net gain of 7 holders — while 55 added to existing stakes and 69 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $14.3M. The largest seller was BlackRock, cutting an estimated $4.91M.

  • 210 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2020, up from 205 in Q2 2020.
  • Funds reported $767M of SANGAMO THERAPEUTICS INC stock for Q3 2020, up 11% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2020 and 25 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2020 was Renaissance Technologies, an estimated $14.3M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2020 was BlackRock, an estimated $4.91M sold.

Based on aggregated 13F filings for Q3 2020.